Penumbra gains amid takeover speculation
2026-01-14 15:29:16 ET
More on Penumbra
- Penumbra, Inc. (PEN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Penumbra: Well-Placed For Above-Average Growth, But Mind The Volatility
- Penumbra, Inc. (PEN) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript
- Intuitive Surgical downgraded as Citi previews 2026 in MedTech
- Penumbra raises 2025 revenue guidance to $1.375B–$1.38B as CAVT and embolization drive growth
Read the full article on Seeking Alpha
For further details see:
Penumbra gains amid takeover speculationNASDAQ: PEN
PEN Trading
0.37% G/L:
$335.67 Last:
112,406 Volume:
$336.33 Open:



